$0.90 EPS Expected for LHC Group, Inc. (LHCG) This Quarter
Wall Street brokerages expect LHC Group, Inc. (NASDAQ:LHCG) to announce $0.90 earnings per share for the current quarter, Zacks Investment Research reports. Five analysts have issued estimates for LHC Group’s earnings. The highest EPS estimate is $0.92 and the lowest is $0.87. LHC Group posted earnings of $0.63 per share during the same quarter last year, which suggests a positive year-over-year growth rate of 42.9%. The company is scheduled to report its next quarterly earnings results on Wednesday, May 1st.
On average, analysts expect that LHC Group will report full year earnings of $4.20 per share for the current year, with EPS estimates ranging from $4.18 to $4.21. For the next financial year, analysts expect that the business will report earnings of $4.55 per share, with EPS estimates ranging from $4.31 to $4.78. Zacks Investment Research’s EPS averages are an average based on a survey of sell-side analysts that that provide coverage for LHC Group.
LHC Group (NASDAQ:LHCG) last released its quarterly earnings results on Wednesday, February 27th. The health services provider reported $1.03 EPS for the quarter, meeting the consensus estimate of $1.03. The business had revenue of $509.80 million for the quarter, compared to analyst estimates of $522.21 million. LHC Group had a net margin of 3.50% and a return on equity of 8.40%. The company’s quarterly revenue was up 75.1% on a year-over-year basis. During the same period in the prior year, the business earned $0.62 earnings per share.
Shares of LHCG stock traded up $1.85 during trading hours on Wednesday, hitting $108.28. The company’s stock had a trading volume of 273,900 shares, compared to its average volume of 249,100. The firm has a market capitalization of $3.34 billion, a PE ratio of 30.50, a P/E/G ratio of 1.87 and a beta of 0.91. LHC Group has a twelve month low of $67.72 and a twelve month high of $115.54. The company has a debt-to-equity ratio of 0.17, a current ratio of 1.78 and a quick ratio of 1.78.
In related news, CEO Keith G. Myers sold 75,000 shares of the firm’s stock in a transaction that occurred on Friday, February 1st. The shares were sold at an average price of $104.69, for a total transaction of $7,851,750.00. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CEO Keith G. Myers sold 5,164 shares of the firm’s stock in a transaction that occurred on Wednesday, April 3rd. The stock was sold at an average price of $108.75, for a total transaction of $561,585.00. Following the sale, the chief executive officer now owns 96,315 shares in the company, valued at approximately $10,474,256.25. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 192,876 shares of company stock worth $20,614,290. 6.80% of the stock is owned by company insiders.
A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. BlackRock Inc. raised its stake in LHC Group by 2.7% during the fourth quarter. BlackRock Inc. now owns 4,566,337 shares of the health services provider’s stock worth $428,687,000 after purchasing an additional 121,385 shares during the period. FMR LLC raised its stake in LHC Group by 24.9% during the fourth quarter. FMR LLC now owns 1,123,833 shares of the health services provider’s stock worth $105,506,000 after purchasing an additional 224,124 shares during the period. Bank of New York Mellon Corp raised its stake in LHC Group by 2.9% during the third quarter. Bank of New York Mellon Corp now owns 732,075 shares of the health services provider’s stock worth $75,394,000 after purchasing an additional 20,567 shares during the period. Norges Bank purchased a new position in LHC Group during the fourth quarter worth approximately $51,535,000. Finally, Thrivent Financial for Lutherans raised its stake in LHC Group by 9.1% during the fourth quarter. Thrivent Financial for Lutherans now owns 530,693 shares of the health services provider’s stock worth $49,822,000 after purchasing an additional 44,450 shares during the period. Hedge funds and other institutional investors own 93.36% of the company’s stock.
LHC Group Company Profile
LHC Group, Inc provides post-acute health care services to patients through its home nursing agencies, hospices and long-term acute care hospitals. The company operates through the following business segments: Home Health Services, Hospice Services, Community-Based Services and Facility-Based Services.
Recommended Story: Insider Trading
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.